Internal Reference Number: FOI_7390
Date Request Received: 21/08/2023 00:00:00
Date Request Replied To: 13/09/2023 00:00:00
This response was sent via: By Email
Request Summary: Dermatological conditions
Request Category: Companies
Question Number 1: How many patients were treated in the last 4 months (April to July 2023) by the dermatology department with each of the following products: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Phototherapy (UVB or PUVA) • Tacrolimus ointment • Tralokinumab • Upadacitinib | |
Answer To Question 1: • Abrocitinib 0 • Acitretin 30 • Alitretinoin <5 • Azathioprine <5 • Baricitinib <5 • Ciclosporin 12 • Dupilumab 20 • Methotrexate 27 • Mycophenolate mofetil 0 • Pimecrolimus 16 • Phototherapy (UVB or PUVA) 26 • Tacrolimus ointment 21 • Tralokinumab <5 • Upadacitinib <5 | |
Question Number 2: How many patients were treated by the dermatology department in the previous 4-month period (December 22 - March 23) with Dupixent? | |
Answer To Question 2: 16 | |
Question Number 3: For patients treated by the dermatology department with Dupilumab in the four months from December 22 to March 2023, could you please tell us: a. How many patients were treated in the subsequent 4-month period (April - July 23) with Dupilumab? b. How many patients were treated in the subsequent 4-month period (April - July 23) with any of the following advanced therapies - Abrocitinib, Baricictinib, Tralokinumab and Upadacitinib? c. How many patients were treated in the subsequent 4-month period (April - July 23) with any of the following immunosuppressants - Methotrexate, Ciclosporin, Mycophenolate or Azathioprine? d. How many patients were treated in the subsequent 4-month period (April - July 23) with any of the following - Acitretin, Alitretoin, Pimecrolimus or Tacrolimus? | |
Answer To Question 3: a) 16 b) 0 c) 0 d) 0 | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.